Clinical Study of Karanj Beej Capsule And Triphala Kwath Vaginal wash In The treatment Of white discharge

Open-Labelled, Randomized, Prospective Controlled Clinical Study To Assess Efficacy and Safety Of Karaj Beej Churna Capsule And Triphala Kwath Yonidhavan In The Management Of Kaphaja Yonivyapad W.S.R. To Vulvo Vaginal Candidiasis - -

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/10/096598

Enrollment

100

Registered

2025-10-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N72- Inflammatory disease of cervix uteri

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Married women aged between 20- 45 years Women who have been screened for symptoms of KaphajaYonivyapad with a duration of less than 6 months will be included regardless of caste, creed, or social status or any other socio-economic or cultural background. Patients willing and able to participate the clinical trial for 1 month.

Exclusion criteria

Exclusion criteria: Unmarried Married Women having cervical erosion more than 6 months Pregnancy. Other Sexually Transmitted Diseases. Diabetes mellitus. Anaemia. Patients with impaired liver function Ovarian cyst,uterine fibroids etc Under prolonged use of antibiotics(more than 1year) Local skin lesions (genital area). Malignant lesions of genital tract. Any condition when the patient is not willing

Design outcomes

Primary

Measure	Time frame
1) To assess the safety and effectiveness of Karanj Beej Churna capsule and Triphala kwath Yonidhavanin female patients suffering from Vulvo vaginal candidiasis. 2) To Compare the effects of Karanj Beej Churna capsuleand Triphala kwath Yonidhavan with only Triphala kwath Yonidhavan group to ascertain its effect on Kaphaja Yonivyapad (Vulvo vaginal candidiasis)Timepoint: Baseline- 1st Week (Day1) 4th Week (Day 15) 5th Week (Day 30)	—

Measure

Time frame

1) To assess the safety and effectiveness of Karanj Beej Churna capsule and Triphala kwath Yonidhavanin female patients suffering from Vulvo vaginal candidiasis. 2) To Compare the effects of Karanj Beej Churna capsuleand Triphala kwath Yonidhavan with only Triphala kwath Yonidhavan group to ascertain its effect on Kaphaja Yonivyapad (Vulvo vaginal candidiasis)Timepoint: Baseline- 1st Week (Day1) 4th Week (Day 15) 5th Week (Day 30)

—

Secondary

Measure	Time frame
1. To review the literature of Kaphaja yonivyapad with special reference Vulvo vaginal candidiasis. 2. To review the literature of Karanj Beej Churna andTriphala kwath 3. To prepare formulation of Karanj Beej Churna capsule and Triphala kwath to standardize it.Timepoint: Follow up will be taken on every 15 days till 1 month, i. e. Day 01 (week 01), Day 15 (week 04), Day 30 (week 05)	—

Countries

India

Contacts

Public ContactDr Divya Ramugade

Dr D Y patil deemed to be university school of ayurveda

divya.ramugade@dypatil.edu9324446071

Outcome results